Ligand validation:4PLE

CPS: 3-[(3-CHOLAMIDOPROPYL)DIMETHYLAMMONIO]-1-PROPANESULFONATE

CPS is a Ligand Of Interest in 4PLE designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4PLE_CPS_G_602	44%	93%	0.11	0.886	0.14	0.32	-	-	0	0	71%	0.7143
4PLE_CPS_C_602	39%	90%	0.11	0.886	0.2	0.39	-	-	0	0	60%	0.5952
4PLE_CPS_A_602	37%	91%	0.109	0.884	0.2	0.38	-	-	0	0	57%	0.5714
4PLE_CPS_E_605	34%	92%	0.123	0.885	0.2	0.31	-	-	0	0	55%	0.5476
4PLE_CPS_A_604	33%	93%	0.13	0.861	0.16	0.32	-	-	0	0	69%	0.6905
4PLE_CPS_E_602	32%	92%	0.126	0.868	0.17	0.37	-	-	0	0	62%	0.619
4PLE_CPS_G_603	27%	92%	0.132	0.857	0.21	0.33	-	-	0	0	55%	0.5476
4PLE_CPS_E_604	25%	92%	0.131	0.84	0.18	0.34	-	-	0	0	57%	0.5714
4PLE_CPS_E_603	19%	93%	0.17	0.812	0.18	0.32	-	-	0	0	74%	0.7381
4PLE_CPS_A_603	19%	91%	0.141	0.817	0.25	0.33	-	-	0	0	52%	0.5238
4PLE_CPS_C_603	12%	90%	0.163	0.772	0.2	0.39	-	-	0	0	57%	0.5714
4PLE_CPS_E_606	11%	92%	0.155	0.749	0.18	0.35	-	-	0	0	57%	0.5714
4PLD_CPS_A_601	15%	2%	0.181	0.743	2.57	4.12	20	32	1	1	100%	1
5FEZ_CPS_A_402	96%	34%	0.057	0.967	1.46	1.15	7	5	0	0	100%	0.9571
3IIX_CPS_A_1701	95%	46%	0.058	0.963	1.33	0.76	1	-	0	0	100%	0.9571
5FF3_CPS_A_402	94%	30%	0.078	0.979	1.58	1.21	3	6	0	0	100%	0.9571
5FEW_CPS_A_402	94%	23%	0.074	0.973	2.03	1.14	7	7	0	0	100%	0.9571
5FES_CPS_A_402	94%	22%	0.069	0.967	1.93	1.35	9	10	0	0	100%	0.9571

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.